Trials
1 active
16 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Postoperative Pain
- Main trialPhase 1
- “This Phase 1, multicenter, open-label, randomized, bupivacaine-controlled study is designed to evaluate the pharmacokinetics (PK) and safety of EXPAREL vs. bupivacaine HCl for postsurgical analgesia in pediatric subjects aged 0 to less than 6 years of age undergoing cardiac surgery, utilizing local infiltration analgesia (LIA).”In the company’s words, NCT06271265 on ClinicalTrials.gov
- Other names
- Liposomal bupivacaine
Other drugs for Postoperative Pain
Coming up1
- Jan 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials16
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | Jan 2027 | Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery | |
| Phase 4Completed | May 2012 | TAP-patients With Robotic Assisted Lap Prostatectomy | |
| Phase 4Terminated | Oct 2012 | EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy | |
| Phase 4Completed | Dec 2012 | EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair | |
| Phase 4Terminated | Dec 2013 | EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries | |
| Phase 4Completed | Apr 2015 | Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy | |
| Phase 4Terminated | Jun 2015 | Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section | |
| Phase 4Completed | 20 Nov 2018 | Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections | |
| Phase 3Completed | Jun 2013 | Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy | |
| Phase 3Completed | 30 Aug 2019 | Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL | |
| Phase 3Completed | 5 Apr 2021 | Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries | |
| Phase 1Completed | Sep 2014 | Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers | |
| Phase 1Completed | 12 Feb 2019 | Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL | |
| Phase 1Completed | 2 Dec 2019 | Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy | |
| Phase 1Completed | 15 Jan 2020 | Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation | |
| Phase 1Terminated | 7 Dec 2020 | Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026